Extending natalizumab up to 8 weeks shown safe and effective in patients with multiple sclerosis, report says

Extending the dose of natalizumab from four weeks up to eight weeks was shown to be well-tolerated and effective in patients, and resulted in no cases of the potentially fatal side effect progressive multifocal leukoencephalopathy, researchers report.
Source: ScienceDaily Headlines - Category: Science Source Type: news